American Century Companies Inc Karuna Therapeutics, Inc. Transaction History

American Century Companies Inc

$160 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $7.26 Million - $14.3 Million	45,064 New	45,064 $14.3 Million
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $128,764 - $170,538	-782 Reduced 1.74%	44,241 $7.48 Million
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $6.39 Million - $8.71 Million	-36,246 Reduced 44.6%	45,023 $9.76 Million
Q1 2023 May 11, 2023	BUY	$161.33 - $204.36 $1.65 Million - $2.09 Million	10,235 Added 14.41%	81,269 $14.8 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $406,235 - $502,295	2,121 Added 3.08%	71,034 $14 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $1.73 Million - $3.87 Million	-13,951 Reduced 16.84%	68,913 $15.5 Million
Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $4.36 Million - $6.65 Million	-46,413 Reduced 35.9%	82,864 $10.5 Million
Q1 2022 May 11, 2022	SELL	$98.9 - $132.37 $53,999 - $72,274	-546 Reduced 0.42%	129,277 $16.4 Million
Q4 2021 Feb 07, 2022	BUY	$110.64 - $159.4 $238,097 - $343,028	2,152 Added 1.69%	129,823 $17 Million
Q3 2021 Nov 10, 2021	SELL	$101.2 - $125.87 $23,782 - $29,579	-235 Reduced 0.18%	127,671 $15.6 Million
Q2 2021 Aug 05, 2021	SELL	$107.45 - $135.95 $1.04 Million - $1.32 Million	-9,705 Reduced 7.05%	127,906 $14.6 Million
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $263,946 - $367,966	-2,765 Reduced 1.97%	137,611 $16.5 Million
Q4 2020 Feb 12, 2021	BUY	$75.23 - $109.23 $627,643 - $911,305	8,343 Added 6.32%	140,376 $14.3 Million
Q3 2020 Nov 13, 2020	BUY	$71.31 - $109.74 $3.8 Million - $5.85 Million	53,290 Added 67.68%	132,033 $10.2 Million
Q2 2020 Aug 13, 2020	BUY	$62.14 - $117.21 $4.89 Million - $9.23 Million	78,743 New	78,743 $8.78 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account